Cargando…

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders with a global burden of approximately 6.1 million patients. Alpha-synuclein has been linked to both the sporadic and familial forms of the disease. Moreover, alpha-synuclein is present in Lewy-bodies, the neuropathologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Fields, Carroll Rutherford, Bengoa-Vergniory, Nora, Wade-Martins, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906193/
https://www.ncbi.nlm.nih.gov/pubmed/31866823
http://dx.doi.org/10.3389/fnmol.2019.00299